Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Magnetic nanoclusters engineered by polymer-controlled self-assembly for the accurate diagnosis of atherosclerotic plaques via magnetic resonance imaging.

Kim MH, Kim B, Lim EK, Choi Y, Choi J, Kim E, Jang E, Park HS, Suh JS, Huh YM, Haam S.

Macromol Biosci. 2014 Jul;14(7):943-52. doi: 10.1002/mabi.201400029.

PMID:
24740644
2.

One-pot synthesis of magnetic nanoclusters enabling atherosclerosis-targeted magnetic resonance imaging.

Kukreja A, Lim EK, Kang B, Choi Y, Lee T, Suh JS, Huh YM, Haam S.

Int J Nanomedicine. 2014 May 21;9:2489-98. doi: 10.2147/IJN.S55525.

3.

Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery.

Li X, Li H, Liu G, Deng Z, Wu S, Li P, Xu Z, Xu H, Chu PK.

Biomaterials. 2012 Apr;33(10):3013-24. doi: 10.1016/j.biomaterials.2011.12.042.

PMID:
22243798
4.

Compensatory UTE/T2W Imaging of Inflammatory Vascular Wall in Hyperlipidemic Rabbits.

Kim B, Yang J, Lee YH, Kim MH, Heo D, Lee E, Suh JS, Haam S, Huh YM.

PLoS One. 2015 May 15;10(5):e0124572. doi: 10.1371/journal.pone.0124572.

5.

Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.

Tu C, Ng TS, Sohi HK, Palko HA, House A, Jacobs RE, Louie AY.

Biomaterials. 2011 Oct;32(29):7209-16. doi: 10.1016/j.biomaterials.2011.06.026.

6.

Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Metz S, Beer AJ, Settles M, Pelisek J, Botnar RM, Rummeny EJ, Heider P.

Int J Cardiovasc Imaging. 2011 Jul;27(6):901-12. doi: 10.1007/s10554-010-9736-7.

PMID:
20972832
7.
8.

Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.

Cheng D, Li X, Zhang C, Tan H, Wang C, Pang L, Shi H.

ACS Appl Mater Interfaces. 2015 Feb 4;7(4):2847-55. doi: 10.1021/am508118x.

PMID:
25569777
9.

Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).

Cheng KK, Chan PS, Fan S, Kwan SM, Yeung KL, Wáng YX, Chow AH, Wu EX, Baum L.

Biomaterials. 2015 Mar;44:155-72. doi: 10.1016/j.biomaterials.2014.12.005.

PMID:
25617135
10.

Evaluation of folate conjugated superparamagnetic iron oxide nanoparticles for scintigraphic/magnetic resonance imaging.

Chauhan RP, Mathur R, Singh G, Kaul A, Bag N, Singh S, Kumar H, Patra M, Mishra AK.

J Biomed Nanotechnol. 2013 Mar;9(3):323-34.

PMID:
23620987
11.

Synthesis and evaluation of a tri-tyrosine decorated dextran MR contrast agent for vulnerable plaque detection.

Beilvert A, Vassy R, Canet-Soulas E, Rousseaux O, Picton L, Letourneur D, Chaubet F.

Chem Commun (Camb). 2011 May 21;47(19):5506-8. doi: 10.1039/c1cc10849b.

PMID:
21455511
12.

Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging.

Arsalani N, Fattahi H, Laurent S, Burtea C, Vander Elst L, Muller RN.

Contrast Media Mol Imaging. 2012 Mar-Apr;7(2):185-94. doi: 10.1002/cmmi.479.

PMID:
22434631
13.

Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.

Burtea C, Ballet S, Laurent S, Rousseaux O, Dencausse A, Gonzalez W, Port M, Corot C, Vander Elst L, Muller RN.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):e36-48. doi: 10.1161/ATVBAHA.112.245415. Erratum in: Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):e103.

14.

Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.

Chan JM, Monaco C, Wylezinska-Arridge M, Tremoleda JL, Gibbs RG.

Eur J Vasc Endovasc Surg. 2014 May;47(5):462-9. doi: 10.1016/j.ejvs.2014.01.017.

15.

Ultra-fast method to synthesize mesoporous magnetite nanoclusters as highly sensitive magnetic resonance probe.

Jia J, Yu JC, Zhu XM, Chan KM, Wang YX.

J Colloid Interface Sci. 2012 Aug 1;379(1):1-7. doi: 10.1016/j.jcis.2012.04.035.

PMID:
22608848
16.
17.

Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.

Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.

Mol Pharm. 2012 Apr 2;9(4):850-61. doi: 10.1021/mp2003863.

PMID:
22352457
18.

Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging.

Li H, Yan K, Shang Y, Shrestha L, Liao R, Liu F, Li P, Xu H, Xu Z, Chu PK.

Acta Biomater. 2015 Mar;15:117-26. doi: 10.1016/j.actbio.2015.01.006.

PMID:
25595473
19.

MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles.

Al Faraj A, Shaik AS, Afzal S, Al Sayed B, Halwani R.

Int J Nanomedicine. 2014 Mar 24;9:1491-503. doi: 10.2147/IJN.S59394.

20.

Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.

Sharma VK, Alipour A, Soran-Erdem Z, Aykut ZG, Demir HV.

Nanoscale. 2015 Jun 21;7(23):10519-26. doi: 10.1039/c5nr00752f.

PMID:
26010145
Items per page

Supplemental Content

Support Center